Primary Site >> Esophagus Cancer
Gene >> HSP90AA1
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Down-regulation of Hsp90 could change cell cycle distribution and increase drug sensitivity of tumor cells. PMID: 11819430 |
Ref: Correlation between tumor-associated proteins and response to neoadjuvant treatment in patients with advanced squamous-cell esophageal cancer. PMID: 21617238 |
Ref: Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells. PMID: 21678497 Ref: Early evaluation of the apoptotic index ratio is useful in predicting the efficacy of chemoradiotherapy in esophageal squamous cell carcinoma. PMID: 22740896 |
Ref: Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer. PMID: 23064324 |
Ref: The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway. PMID: 24317439 |
Ref: Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells. PMID: 25333998 Ref: The Prognostic Impact of Heat Shock Proteins Expression in Patients with Esophageal Cancer: A Meta-Analysis. PMID: 26446629 |
Ref: Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer. PMID: 28831912 Ref: Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma. PMID: 29331417 Ref: Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90. PMID: 29665050 |